These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Müller MC, Gattermann N, Lahaye T, Deininger MW, Berndt A, Fruehauf S, Neubauer A, Fischer T, Hossfeld DK, Schneller F, Krause SW, Nerl C, Sayer HG, Ottmann OG, Waller C, Aulitzky W, le Coutre P, Freund M, Merx K, Paschka P, König H, Kreil S, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A. Leukemia; 2003 Dec; 17(12):2392-400. PubMed ID: 14523462 [Abstract] [Full Text] [Related]
47. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha). Steegmann JL, Requena MJ, Casado LF, Pico M, Peñarrubia MJ, Ferro MT, Resino M, Fernandez-Rañada JM. Am J Hematol; 1996 Nov; 53(3):169-74. PubMed ID: 8895687 [Abstract] [Full Text] [Related]
54. A long-term suppression by alpha-interferon of Philadelphia chromosome in children with chronic myelogenous leukemia. Kikawa Y, Fuji Y, Takano T, Shigematsu Y, Sudo M, Okamoto M, Mizutani S. Acta Paediatr Jpn; 1993 Aug; 35(4):361-4. PubMed ID: 8379332 [Abstract] [Full Text] [Related]
60. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Buño I, Wyatt WA, Zinsmeister AR, Dietz-Band J, Silver RT, Dewald GW. Blood; 1998 Oct 01; 92(7):2315-21. PubMed ID: 9746769 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]